MR编号 | NL/H/3657/003 |
---|
药品名称 | Erlotinib Sandoz 100 mg, film-coated tablet |
---|
活性成分 | - erlotinib hydrochloride 150.0 mg
|
---|
剂型 | Film-coated tablet |
---|
上市许可持有人 | Sandoz B.V.
Veluwezoom 22,
1327 AH Almere
The Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) Erlotinib Sandoz 100 mg, filmomhulde tabletten |
---|
互认成员国 - 产品名称 | - Belgium (BE)
- Bulgaria (BG)
Erlotinib Sandoz - Cyprus (CY)
ERLOTINIB HYDROCHLORIDE SANDOZ - Czechia (CZ)
Erlotinib Sandoz 150 mg - Germany (DE)
Elortinib HEXAL 150 mg Filmtabletten - Denmark (DK)
Erlotinib "Sandoz" - Estonia (EE)
- Spain (ES)
- France (FR)
- Croatia (HR)
- Hungary (HU)
- Ireland (IE)
- Lithuania (LT)
Erlotinib Sandoz 150 mg plėvele dengtos tabletės - Latvia (LV)
- Poland (PL)
Erlotinib Sandoz - Portugal (PT)
- Romania (RO)
- Sweden (SE)
- Slovenia (SI)
- Slovakia (SK)
Erlotinib Sandoz 150 mg
|
---|
许可日期 | 2017/03/15 |
---|
最近更新日期 | 2017/10/06 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Withdrawn(注:已撤市) |
---|